These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11181385)

  • 21. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
    Prado V; Giangrieco M; Durán C; Ojeda A; van Flaskamp R
    Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
    Coyle EA; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1654-9. PubMed ID: 11353608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
    Roychoudhury S; Catrenich CE; McIntosh EJ; McKeever HD; Makin KM; Koenigs PM; Ledoussal B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1115-20. PubMed ID: 11257024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998.
    Huczko E; Conetta B; Bonner D; Valera L; Stickle T; Macko A; Fung-Tomc J
    Int J Antimicrob Agents; 2000 Dec; 16(4):401-5. PubMed ID: 11118848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Propensity of fluoroquinolones with different moieties at position 8 to cause resistance development in clinical isolates of Streptococcus pneumoniae.
    Schmitz FJ; Boos M; Mayer S; Hafner D; Jagusch H; Verhoef J; Fluit AC
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2666-7. PubMed ID: 11523528
    [No Abstract]   [Full Text] [Related]  

  • 26. Bactericidal mechanism of gatifloxacin compared with other quinolones.
    Gradelski E; Kolek B; Bonner D; Fung-Tomc J
    J Antimicrob Chemother; 2002 Jan; 49(1):185-8. PubMed ID: 11751786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to clinafloxacin.
    Harrington GD; Zarins LT; Ramsey MA; Bradley SF; Kauffman CA
    Diagn Microbiol Infect Dis; 1995 Jan; 21(1):27-31. PubMed ID: 7789094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SYN987, SYN1193, and SYN1253, new quinolones highly active against gram-positive cocci.
    Kitzis MD; Goldstein FW; Ishida N; Acar JF
    J Antimicrob Chemother; 1995 Jul; 36(1):209-13. PubMed ID: 8537267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activities of six different quinolones against clinical respiratory isolates of Streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain.
    Pérez-Trallero E; García-Rey C; Martín-Sánchez AM; Aguilar L; García-de-Lomas J; Ruiz J;
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2665-7. PubMed ID: 12121952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae.
    Dalhoff A
    Drugs; 1995; 49 Suppl 2():194-6. PubMed ID: 8549301
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of subinhibitory concentrations of moxifloxacin in an in-vitro dynamic model.
    Maggiolo F; Capra R; Bartoli A; Bottura P; Migliorino M; Suter F
    J Chemother; 2000 Apr; 12(2):129-33. PubMed ID: 10789551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae.
    Boswell FJ; Andrews JM; Wise R
    J Antimicrob Chemother; 2001 Sep; 48(3):446-7. PubMed ID: 11533016
    [No Abstract]   [Full Text] [Related]  

  • 33. Bactericidal activities of DU-6859a and clinafloxacin (CI-960) against staphylococci.
    Forstall GJ; Knapp CC; Washington JA
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1868-70. PubMed ID: 7986024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incomplete cross-resistance between ciprofloxacin and sparfloxacin in staphylococci, with a note on selection pressure due to clinical use of ciprofloxacin.
    Brumfitt W; Hamilton-Miller JM
    J Antimicrob Chemother; 1993 Apr; 31(4):610-2. PubMed ID: 8390435
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of agar dilution, microdilution, Etest and disc diffusion to test the activity of trovafloxacin against Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae.
    Kelly LM; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1999 May; 43(5):707-9. PubMed ID: 10382894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new quinolones.
    Balcabao IP; Alou L; Aguilar L; Gomez-Lus ML; Giménez MJ; Prieto J
    J Antimicrob Chemother; 2001 Dec; 48(6):907-9. PubMed ID: 11733477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2431-3. PubMed ID: 8891160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.
    Odenholt-Tornqvist I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1852-8. PubMed ID: 1329631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The new 4-quinolones DU-6859a and DV-7751a show enhanced activity against Streptococcus pneumoniae.
    Morrissey I; Smith JT
    Drugs; 1995; 49 Suppl 2():228-9. PubMed ID: 8549312
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of gatifloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a granulocyte-rich exudate.
    Trampuz A; Laifer G; Wenk M; Rajacic Z; Zimmerli W
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3630-3. PubMed ID: 12384378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.